---
figid: PMC6225117__molecules-23-02334-g001
figlink: /pmc/articles/PMC6225117/figure/molecules-23-02334-f001/
number: F1
caption: 'Molecular mechanisms of (-)-epigallocatechingallate (EGCG) suppressing the
  proliferation of cervical cancer cells. EGCG down-regulated the expressions of E6,
  E7, EGFR, IGF-1 and HIF-1, then the expressions of downstream targets such as the
  AKT/PI3K pathway, mTOR pathway and ERK1/2 also declined. The decline of E6 could
  up-regulated P53 expression resulting in P21 and P27 up-regulations, then CDK2 was
  down-regulated. The down-regulation of the mTOR pathway led to VEGF reduction. Eventually,
  the reduced expressions of ERK1/2, VEGF and CDK2 suppressed the proliferation of
  cervical cancer cells (broken lines mean indirect approaches). AKT: protein kinase
  B; CDK2: cyclin-dependent kinase 2; E6: one of human papillomavirus (HPV) oncogenes;
  E7: another HPV oncogene; EGFR: epidermal growth factor receptor; ERK: extracellular
  signal-regulated kinase; HIF-1: hypoxia-inducible factor 1; IGF-1: insulin-like
  growth factor 1; mTOR: mammalian target of rapamycin; P21: tumor suppressor protein;
  P27: tumor suppressor protein; P53: tumor suppressor protein; PI3K: phosphoinositide-3-kinase;
  VEGF: vascular endothelial growth factor.'
pmcid: PMC6225117
papertitle: Suppressive Effects of EGCG on Cervical Cancer.
reftext: Ying-Qi Wang, et al. Molecules. 2018 Sep;23(9):2334.
pmc_ranked_result_index: '90726'
pathway_score: 0.7137995
filename: molecules-23-02334-g001.jpg
figtitle: Molecular mechanisms of (-)-epigallocatechingallate (EGCG) suppressing the
  proliferation of cervical cancer cells
year: '2018'
organisms:
- Homo sapiens
ndex: a5a4edf1-dea9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6225117__molecules-23-02334-g001.html
  '@type': Dataset
  description: 'Molecular mechanisms of (-)-epigallocatechingallate (EGCG) suppressing
    the proliferation of cervical cancer cells. EGCG down-regulated the expressions
    of E6, E7, EGFR, IGF-1 and HIF-1, then the expressions of downstream targets such
    as the AKT/PI3K pathway, mTOR pathway and ERK1/2 also declined. The decline of
    E6 could up-regulated P53 expression resulting in P21 and P27 up-regulations,
    then CDK2 was down-regulated. The down-regulation of the mTOR pathway led to VEGF
    reduction. Eventually, the reduced expressions of ERK1/2, VEGF and CDK2 suppressed
    the proliferation of cervical cancer cells (broken lines mean indirect approaches).
    AKT: protein kinase B; CDK2: cyclin-dependent kinase 2; E6: one of human papillomavirus
    (HPV) oncogenes; E7: another HPV oncogene; EGFR: epidermal growth factor receptor;
    ERK: extracellular signal-regulated kinase; HIF-1: hypoxia-inducible factor 1;
    IGF-1: insulin-like growth factor 1; mTOR: mammalian target of rapamycin; P21:
    tumor suppressor protein; P27: tumor suppressor protein; P53: tumor suppressor
    protein; PI3K: phosphoinositide-3-kinase; VEGF: vascular endothelial growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - MAPK1
  - CDK2
  - AKT2
  - PIK3R5
  - PIK3R6
  - PIK3R4
  - EGFR
  - SETD2
  - IGF1
  - PGF
  - MAPK3
  - PIK3CB
  - PIK3CD
  - TP53
  - VEGFA
  - VEGFB
  - VEGFC
  - MTOR
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - VEGFD
  - EGCG
  - Cancer
genes:
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: AKT/PI3K
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
chemicals:
- word: EGCG
  source: MESH
  identifier: C045651
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6225117__F1
redirect_from: /figures/PMC6225117__F1
figtype: Figure
---
